Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An enzyme-linked immunosorbent assay for platelet compatibility testing.

J D Tamerius, J G Curd, P Tani

    Blood
    |October 1, 1983
    PubMed
    Summary

    This study introduces an enzyme-linked immunosorbent assay (ELISA) to identify compatible platelet donors for patients refractory to platelet transfusions, improving transfusion success rates.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Sex differences in voluntary running behavior between C57BL/6 and BALB/cJ mouse strains do not correspond to changes in VO2 and RER.

    Physiological reports·2025
    Same author

    Validation of an Oral Disease Severity Score (ODSS) tool for use in oral mucous membrane pemphigoid.

    The British journal of dermatology·2019
    Same author

    Updated European Consensus Statement on diagnosis and treatment of adult ADHD.

    European psychiatry : the journal of the Association of European Psychiatrists·2018
    Same author

    Day-case holmium laser enucleation of the prostate: feasibility, safety and predictive factors.

    Annals of the Royal College of Surgeons of England·2018
    Same author

    An Oral Disease Severity Score validated for use in oral pemphigus vulgaris.

    The British journal of dermatology·2018
    Same author

    Orofacial pain - an update on diagnosis and management.

    British dental journal·2017

    Area of Science:

    • Immunology
    • Transfusion Medicine
    • Clinical Laboratory Science

    Background:

    • Platelet transfusion refractoriness is a significant clinical challenge.
    • Identifying compatible platelet donors is crucial for effective treatment.

    Purpose of the Study:

    • To describe and validate an enzyme-linked immunosorbent assay (ELISA) for detecting platelet alloantibodies in refractory patients.
    • To assess the clinical utility of the ELISA in selecting compatible platelet donors.

    Main Methods:

    • An ELISA was developed to evaluate alloantibodies by immobilizing donor platelets and detecting patient IgG.
    • Serum from refractory patients was tested against platelets from 46 prospective donors.
    • Platelet increments were measured post-transfusion to correlate with ELISA results.

    Main Results:

    • Twenty-two of 46 donors were compatible (titer < 16) via ELISA; 15 yielded measurable platelet increments.
    • Higher platelet increments correlated with lower antibody titers (titer < 4).
    • Incompatible donors (titer > 16) often resulted in no increment or adverse reactions.

    Conclusions:

    • The ELISA is a sensitive, simple, and adaptable method for selecting compatible platelet donors.
    • This assay can improve transfusion outcomes for patients refractory to random donor platelets.
    • Stored, plated platelets from donor panels can be utilized for up to 6 months.

    Related Experiment Videos